Modification of microflora imbalance: Future directions in prevention and treatment of colorectal cancer?

Neoplasma

Volumn 62, Issue 3, 2015, Pages 345-352

  Ciernikova, S ^a   Mego, M ^b   Hainova, K ^a   Adamcikova, Z ^a   Stevurkova, V ^a   Zajac, V ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

Bacterial vectors; Cancer prevention and treatment; Colorectal cancer; Intestinal bacteria; Microflora dysbiosis; Probiotics

Indexed keywords

BACTERIAL VECTOR; GREEN FLUORESCENT PROTEIN; KRUPPEL LIKE FACTOR 4; PROBIOTIC AGENT; TRANSCRIPTION FACTOR HES 1;

BACTERIAL COLONIZATION; CARCINOGENESIS; COLORECTAL CANCER; DIET; DYSBIOSIS; FAMILIAL COLON POLYPOSIS; GENE THERAPY; HORIZONTAL GENE TRANSFER; HUMAN; INFLAMMATION; INTESTINE CELL; INTRACELLULAR BACTERIUM; MICROBIOME; MICROFLORA; MYELOID LEUKEMIA; NONHUMAN; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TUMOR CELL;

EID: 84969593583     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2015_042     Document Type: Review

References (79)

1. BACKHED F, LEY RE, SONNENBURG JL, PETERSON DA, GORDON JI. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920. http: //dx. doi. org/10. 1126/ science. 1104816
2. TLASKALOVA-HOGENOVA H, STEPANKOVA R, KOZAKOVA H, HUDCOVIC T, VANNUCCI L et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cellular & Molecular Immunology 2011; 8: 110-120. http: //dx. doi. org/10. 1038/cmi. 2010. 67
3. MARIAT D, FIRMESSE O, LEVENEZ F, GUIMARAES VD, SOKOL H et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiology 2009; 9: 123. http: //dx. doi. org/10. 1186/1471-2180-9-123
4. ROGER LC, MCCARTNEY AL. Longitudinal investigation of the faecal microbiota of healthy full-term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis. Microbiology 2010; 156: 3317-28. http: // dx. doi. org/10. 1099/mic. 0. 041913-0
5. ROGER LC, COSTABILE A, HOLLAND DT, HOYLES L, MCCARTNEY AL. Examination of faecal Bifidobacterium populations in breast-and formula-fed infants during the first 18 months of life. Microbiology 2010; 156: 3329-41. http: // dx. doi. org/10. 1099/mic. 0. 043224-0
6. FAVIER CF, VAUGHAN EE, DE VOS WM, AKKERMANS ADL. Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiology 2002; 68: 219-226. http: //dx. doi. org/10. 1128/AEM. 68. 1. 219-226. 2002
7. TOJO R, SUAREZ A, CLEMENTE MG, DE LOS REYES-GAVILAN CG, MARGOLLES A et al. Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis. World J Gastroenterol. 2014; 20(41): 15163-15176. http: // dx. doi. org/10. 3748/wig. v20. i41. 15163
8. HORNEF MW, WICK MJ, RHEN M, NORMARK S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nature Immunology 2002; 3: 1033-1040. http: // dx. doi. org/10. 1038/nil 102-1033
9. PROCTOR LM. The Human Microbiome Project in 2011 and beyond. Cell Host Microbe. 2011; 10: 287-91. http: //dx. doi. org/10. 1016/j. chom. 2011. 10. 001
10. PETERSON J, GARGES S, GIOVANNI M, MCINNES P, WANG et al. The NIH Human Microbiome Project. Genome Res. 2009; 19: 2317-2323. http: //dx. doi. org/10. 1101/ gr. 096651. 109
11. THE HUMAN MICROBIOME CONSORTIUM. A framework for human microbiome research. Nature 2012; 486: 215-221. http: //dx. doi. org/10. 1038/naturell209
12. THE HUMAN MICROBIOME CONSORTIUM. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214. http: //dx. doi. org/10. 1038/na-ture11234
13. DING T, SCHLOSS PD. Dynamics and associations of microbial community types across the human body Nature 2014; 509(7500): 357-60. http: //dx. doi. org/10. 1038/ nature13178
14. TJALSMA H, BOLEIJ A, MARCHESI J, DUTILH B. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 2012; 10: 575-582. http: // dx. doi. org/10. 1038/nrmicro2819
15. BECKER S, OELSCHLAEGER TA, WULLAERT A, VLAN-TIS K, PASPARAKIS M, et al. Bacteria Regulate Intestinal Epithelial Cell Differentiation Factors Both In Vitro and In Vivo. PLoS ONE 2013; 8: e55620. http: //dx. doi. org/10. 1371/ iournal. pone. 0055620
16. FEARON ER. Molecular genetic of colorectal cancer. Annu Rev Pathol 2011; 6: 479-507. http: //dx. doi. org/10. 1146/ annurev-pathol-011110-130235
17. ECKBURG PB, BIK EM, BERNSTEIN CN, PURDOM E, DETHLEFSEN L, et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-8. http: //dx. doi. org/10. 1126/science. 1110591
18. PALMER J, FLINT S, BROOKS J. Bacterial cell attachment, the beginning of a biofilm. J Ind Microbiol Biotechnol. 2007; 34: 577-88. http: //dx. doi. org/10. 1007/s10295-007-0234-4
19. DE MARTEL C, FRANCESCHI S. Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol. 2009; 70: 183-94. http: //dx. doi. Org/10. 1016/j. critrevonc. 2008. 07. 021
20. PEEK RM Jr, BLASER MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002; 2: 28-37. http: //dx. doi. org/10. 1038/nrc703
21. PARSONNET J, HANSEN S, RODRIGUEZ L, GELB AB, WARNKE RA et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994; 330: 1267-71. http: //dx. doi. org/10. 1056/NEJM199405053301803
22. VOGELMANN R, AMIEVA MR. The role of bacterial pathogens in cancer. Curr Opin Microbiol. 2007; 10: 76-81. http: // dx. doi. org/10. 1016/j. mib. 2006. 12. 004
23. HOOPER LV, MACPHERSON AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nature Reviews Immunology 2010; 10: 159-169. http: //dx. doi. org/10. 1038/nri2710
24. OOSTINDJER M, ALEXANDER J, AMDAM GV, ANDERSEN G, BRYAN NS et al. The role of red and processed meat in colorectal cancer development: a perspective. Meat Sci. 2014; 97: 583-96. http: //dx. doi. Org/10. 1016/j. meatsci. 2014. 02. 011
25. CHAN AT, Giovannucci, EL. Primary prevention of colorectal cancer. Gastroenterology 2010; 138: 2029-2043. http: //dx. doi. org/10. 1053/j. gastro. 2010. 01. 057
26. ZACKULAR JP, ROGERS MA, RUFFIN MT 4TH, SCHLOSS PD. The human gut microbiome as a screeningtool for colorectal cancer Cancer Prev Res (Phila). 2014; 7(11): 1112-21. http: //dx. doi. org/10. 1158/1940-6207. CAPR-14-0129
27. CASTELLARIN M, WARREN RL, FREEMAN JD, DREO-LINI L, KRZYWINSKI M et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012; 22: 299-306. http: //dx. doi. org/10. 1101/ gr. 126516. 111
28. KOSTIC AD, CHUN E, MEYERSON M, GARRETT WS. Microbes and inflammation in colorectal cancer. Cancer Immunol Res. 2013; 1: 150-7. http: //dx. doi. org/10. 1158/2326-6066. CIR-13-0101
29. LUPERCHIO SA, SCHAUER DB. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 2001; 3: 333-340. http: //dx. doi. org/10. 1016/S 1286-4579(01)01387-9
30. NEWMAN JV, KOSAKA AT, SHEPPARD BJ, FOX JG, SCHAUER DB. Bacterial Infection Promotes Colon Tumori-genesis in ApcMin/+ Mice. The Journal of Infectious Diseases 2001; 184: 227-30. http: //dx. doi. org/10. 1086/321998
31. ZHU K, DEVESA SS, WU H, ZAHM SH, JATO H et al. Cancer incidence in the U. S. military population: comparison with rates from the SEER program. Cancer Epidemiol Biomarkers Prev 2009; 18: 1740-1745. http: //dx. doi. org/10. 1158/1055-9965. EPI-09-0041
32. ZHANG B, IZADJOO M, HORKAYNE-SZAKALY I, MORRISON A, WEAR DJ. Medulloblastoma and Brucellosis-Molecular Evidence of Brucella sp in Association with Central Nervous System Cancer. J Cancer 2011; 12: 136-141. http: //dx. doi. Org/10. 7150/jca. 2. 136
33. ANTONIC V, STOJADINOVIC A, KESTER KE, WEINA PJ, BRUCHER BL et al. Significance of infectious agents in colorectal cancer development. J Cancer 2013; 4: 227-240. http: //dx. doi. org/10. 7150/jca. 5835
34. SHEN XJ, RAWLS JF, RANDALL T, BURCAL L, MPANDE CN et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes. 2010; 1: 138-47. http: //dx. doi. org/10. 4161/ gmic. 1. 3. 12360
35. SWIDSINSKI A, KHILKIN M, KERJASCHKI D, SCHREIB-ER S, ORTNER M, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998; 115: 281-286. http: //dx. doi. org/10. 1016/S0016-5085-(98)70194-5
36. MEGO M, MAJEK J, KONCEKOVA R, EBRINGER L, CIERNIKOVA S et al. Intramucosal bacteria in colon cancer and their elimination by probiotic strain Enterococcus faecium M-74 with organic selenium. Folia Microbiol (Praha) 2005; 50: 443-7. http: //dx. doi. org/10. 1007/BF02931427
37. ABDULAMIR AS, HAFIDH RR, MAHDI LK, AL-JEBOORI T, ABUBAKER F. Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer 2009; 9: 403. http: //dx. doi. org/10. 1186/1471-2407-9-403
38. GUPTA A, MADANI R, MUKHTAR H. Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal Dis 2010; 12: 164-171. http: //dx. doi. Org/10. 1111/j. 1463-1318. 2009. 01814. x
39. GRILLOT-COURVALIN C, GOUSSARD S, COURVALIN P. Bacteria as Gene Delivery Vectors for Mammalian Cells. Current Opinion in Biotechnology 1999; 10: 477-481. http: // dx. doi. org/10. 1016/S0958-1669(99)00013-0
40. WATERS VL. Conjugation between bacterial and mammalian cells. Nat Genet. 2001; 29: 375-6. http: //dx. doi. org/10. 1038/ ng779
41. HOTOPP JCD, CLARK ME, OLIVEIRA DC, FOSTER JM, FISCHER P et al. Widespread lateral gene transfer from intracellular bacteria to multicellular eukaryotes. Science. 2007; 317: 1753-6. http: //dx. doi. org/10. 1126/ science. 1142490
42. HOTOPP JCD. Horizontal gene transfer between bacteria and animals. Trends Genet. 2011; 27: 157-63. http: //dx. doi. org/10. 1016/j. tig. 2011. 01. 005
43. LURIE-WEINBERGER MN, GOMEZ-VALERO L, MER-AULT N, GLOCKNER G, BUCHRIESER C et al. The origins of eukaryotic like proteins in Legionella pneumophila. Int J Med 2010; 300: 470-81.
44. LURIE-WEINBERGER MN, PEERI M, TULLER T, GOPH-NA U. Extensive Inter-Domain Lateral Gene Transfer in the Evolution of the Human Commensal Methanosphaera stadtmanae Front Genet. 2012; 3: 182.
45. RILEY DR, SIEBER KB, ROBINSON KM, WHITE JR, GANESAN A et al. Bacteria-Human Somatic Cell Lateral Gene Transfer Is Enriched in Cancer Samples. PLoS Comput Biol 2013; 9: el003107. http: //dx. doi. org/10. 1371/journal. pcbi. 1003107
46. HOLEC V, CIERNIKOVA S, WACHSMANNOVA L, AD-AMCIKOVA Z, HAINOVA K ET AL. Analysis of bacteria from intestinal tract of FAP patients for the presence of APC-like sequences. Med Sci Moni. 2012; 18: CR486-492. http: //dx. doi. org/10. 12659/MSM. 883268
47. HAINOVA K, ADAMCIKOVA Z, CIERNIKOVA S, STE-VURKOVA V, TYCIAKOVA S et al. Intestinal flora of FAP patients containing APC-like sequences. Neoplasma. 2014; 61: 283-90. http: //dx. doi. org/10. 4149/neo 2014 036
48. FAO, WHO: Evaluation of health and nutritional properties of probiotics in food, including powder milk with live lactic acid bacteria. Food and Agricultural Organization of United Nations and World Health Organization Expert Consultation report 2001.
49. HUEBNER ES, SURAWICZ CM. Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol Clin North Am 2006; 35: 355-65. http: //dx. doi. Org/10. 1016/j. gtc. 2006. 03. 005
50. SCALDAFERRI F, GERARDI V, LOPETUSO LR, DEL ZOMPO F, MANGIOLA F, et al. Gut microbial flora, prebi-otics, and probiotics in IBD: their current usage and utility. Biomed Res Int. 2013; 435268.
51. SAKAMOTO I, IGARASHI M, KIMURA K, TAKAGI A, MIWA T et al. Suppressive effect of Lactobacillus gasseri OLL2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother. 2001; May; 47: 709-10. http: //dx. doi. org/10. 1093/jac/47. 5. 709
52. HICKSON, D'SOUZA AL, MUTHU N, ROGERS TR, WANT S et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007; 335: 80. http: // dx. doi. org/10. 1136/bmj. 39231. 599815. 55
53. HICKSON M. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therap Adv Gastroenterol. 2011; 4: 185-97. http: //dx. doi. org/10. 1177/1756283X11399115
54. DELIA P, SANSOTTA G, DONATO V, MESSINA G, FROSINA P et al. Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastroenterol. 2002; 97: 2150-2. http: //dx. doi. org/10. 1111/j. 1572-0241. 2002. 05946. x
55. URBANCSEK H, KAZAR T, MEZES I, NEUMANN K. Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol. 2001; 13: 391-396. http: //dx. doi. org/10. 1097/00042737-200104000-00015
56. ROUND JL, MAZMANIAN SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009; 9: 313-23. http: //dx. doi. org/10. 1038/ nri2515
57. MA EL, CHOI YJ, CHOI J, POTHOULAKIS C, RHEE SH et al. The anticancer effect of probiotic Bacillus polyfer-menticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. Int J Cancer. 2010; Aug 15; 127: 780-90. 4
58. VAN LOO J, CLUNE Y, BENNETT M, COLLINS JK. The SYNCAN project: goals, set-up, first results and settings of the human intervention study. Br J Nutr 2005; 93 Suppl 1: S91-8. http: //dx. doi. org/10. 1079/BIN20041353
59. PALA V, SIERI S, BERRINO F, VINEIS P, SACERDOTE C et al. Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort. Int J Cancer. 2011; 129: 2712-9. http: // dx. doi. org/10. 1002/ijc. 26193
60. WOLLOWSKI I, JI ST, BAKALINSKY AT, NEUDECKER C, POOL-ZOBEL BL. Bacteria used for the production ofyogurt inactivate carcinogens and prevent DNA damage in the colon of rats. J Nutr. 1999; 129: 77-82.
61. MEGO M, HOLEC V, DRGONA L, HAINOVA K, CIERNIKOVA S et al. Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy. Complement Ther Med. 2013; 21: 712-23. http: //dx. doi. Org/10. 1016/j. ctim. 2013. 08. 018
62. MEGO M, EBRINGER L, DRGONA L, MARDIAK J, TRUPL J et al. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. Neoplasma 2005; 52: 159-64.
63. MEGO M, KONCEKOVA R, MIKUSKOVA E, DRGONA L, EBRINGER L et al. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study. Support Care Cancer. 2006; 14: 285-90. http: //dx. doi. org/10. 1007/s00520-005-0891-7
64. MEGO M, CHOVANEC J, ANDREZALOVA I, KONKOLOVSKY P, MIKULOVA M et al. Prevention of irinotecan-induced diarrhea by probiotics: Randomized double-blind, placebo-controlledphase III study. J Clin Oncol 2014; 32: 5s (suppl; abstr 9611).
65. REDMAN MG, WARD EJ, PHILLIPS RS. The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol. 2014; 25: 1919-29. http: //dx. doi. org/10. 1093/ annonc/mdul06
66. GARMORY HS, LEARY SE, GRIFFIN KF, WILLIAMSON ED, BROWN KA et al. The use of live attenuated bacteria as a delivery system for heterologous antigens. J Drug Target. 2003; 11: 471-9. http: //dx. doi. org/10. 1080/10611860410001670008
67. CRONIN M, STANTON RM, FRANCIS KP, TANGNEY M. Bacterial vectors for imaging and cancer gene therapy: a review. Cancer Gene Ther. 2012; 19: 731-40. http: //dx. doi. org/10. 1038/cgt. 2012. 59
68. BABAN CH K, CRONIN M, O'HANLON D, O'SULLIVAN GC, TANGNEY M. Bacteria as vectors for gene therapy of cancer. Bioeng Bugs. 2010; 1: 385-394. http: //dx. doi. org/10. 4161/ bbug. l. 6. 13146
69. CELEC P, GARDLIK R, PALFFY R, HODOSY J, STUCHLIK S et al. The use of transformed Escherichia coli for experimental angiogenesis induced by regulated in situ production of vascular endothelial growth factor-an alternative gene therapy. Med Hypotheses. 2005; 64: 505-11. http: //dx. doi. org/10. 1016/j. mehv. 2004. 07. 039
70. PALFFY R, GARDLIK R, HODOSY J, BEHULIAK M, RESKO P et al. Bacteria in gene therapy: bactofection versus alternative gene therapy Gene Therapy 2006; 13: 101-105. http: //dx. doi. org/10. 1038/si. gt. 3302635
71. CRONIN M, MORRISSEY D, RAJENDRAN S, EL MASHAD SM, VAN SINDEREN D et al. Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors. Mol Ther. 2010; 18: 1397-1407. http: //dx. doi. org/10. 1038/ mt. 2010. 59
72. ADAMCIKOVA Z, WACHSMANNOVA L, HAINOVA K, STEVURKOVA V, HOLEC V et al. Study of the APC gene function in the mouse APC+/APC1638N model. Neuro Endocrinol Lett. 2012; 3326-33.
73. VASSAUX G, NITCHEU J, JEZZARD S, LEMOINE NR. Bacterial gene therapy strategies. J Pathol. 2006; 208: 290-298. http: //dx. doi. org/10. 1002/path. 1865
74. XIANG S, FRUEHAUF J, LI CHJ. Short hairpin RNA-ex-pressing bacteria elicit RNA interference in mammals. Nature Biotechnology 2006; 24: 697-702. http: //dx. doi. org/10. 1038/ nbtl211
75. SIZEMORE DR, BRANSTROM AA, SADOFF JC. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 1995; 270: 299-302. http: //dx. doi. org/10. 1126/science. 270. 5234. 299
76. BUTTARO C, FRUEHAUF JH. Engineered E. coli as vehicles for targeted therapeutics. Curr Gene Ther. 2010; 10: 27-33. http: //dx. doi. org/10. 2174/156652310790945593
77. NARAYANAN K, LEE CW, RADU A, SIM EU. Escherichia coli bactofection using Lipofectamine. Anal Biochem. 2013; 2: 142-4. http: //dx. doi. Org/10. 1016/j. ab. 2013. 04. 010
78. ZURITA-TURK M, DEL CARMEN S, SANTOS AC, PEREIRA VB, CARA DC et al. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis. BMC Biotechnol. 2014; 14: 73. http: //dx. doi. org/10. 1186/1472-6750-14-73
79. GUIMARAES V, INNOCENTIN S, CHATEL JM, LEFEVRE F, LANGELLA P, et al. A new plasmid vector for DNA delivery using lactococci. Genetic Vaccines and Therapy 2009; 7: 4. http: //dx. doi. org/10. 1186/1479-0556-7-4